The Medical Letter on Drugs and Therapeutics
FROM
ISSUE 1265
ISSUE 1265
July 16, 2007
Issue 1265
Subscribers: Log in to read full issue. Not a subscriber? Subscribe or purchase issue.
Thiazolidinediones and Cardiovascular Disease
July 16, 2007 (Issue: 1265)
The thiazolidinediones rosiglitazone (Avandia) and pioglitazone (Actos) are peripheral insulin sensitizing agents used to treat hyperglycemia in patients with type 2 diabetes; one or the other is often used as a second or third agent with metformin...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.